Sarah Woolsey

CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease

Sarah Woolsey, Sara E. Mansell, Richard B. Kim et al. · Drug Metabolism and Disposition · 2015 · 129 citations

Medicine, Biochemistry, Pharmacology +16

Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease

Aze Wilson, Wendy A. Teft, Bridget L. Morse et al. · Digestive Diseases and Sciences · 2015 · 95 citations

Veterinary Medicine, Molecular Medicine, Pharmacology +13

Going Mobile With Diabetes Support: A Randomized Study of a Text Message–Based Personalized Behavioral Intervention for Type 2 Diabetes Self-Care

Korey Capozza, Sarah Woolsey, Mattias Georgsson et al. · Diabetes Spectrum · 2015 · 87 citations · Full text

Computing, Health Behavior, Health Promotion +17

Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response

Inna Y. Gong, Natalie Crown, Colin Suen et al. · European Heart Journal · 2012 · 86 citations

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacist-provided diabetes management and education via a telemonitoring program

Laura Shane‐McWhorter, Carrie McAdam‐Marx, Leslie Lenert et al. · Journal of the American Pharmacists Association · 2015 · 62 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +14